The TransEnterix European Patient Registry
ConditionSurgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorAsensus Surgical
About this trial
An open label observational registry trial in which participating centers enroll subjects who had or will have a laparoscopically assisted surgery using the Senhance Surgical System.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients 18-80 years old
Signed the informed consent
life expectancy 12 months or more
Disqualifiers
None
Trial population
Patients at a participating center who have had or are scheduled to have surgery using the Senhance system
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Surgery
DevicePatients are approached surgically with the Senhance Surgical System
Treatment groups
500 Participants
are divided into 1 treatment groupGroup A: Senhance Treated1 intervention
Trial outcomes
Primary outcomes
1
Adverse Event
Any untoward sign symptom or disease
Time frame
Surgery to 30 days post opSponsors and contacts
Click on the lead sponsor to view all of their trials.
Asensus Surgical
Lead sponsor
RQM+
Collaborator
Source ClinicalTrials.gov